外泌体来源miRNA在术后脓毒性休克与非脓毒性休克患者中的诊断作用研究
本研究为多中心前瞻性研究,纳入两所西班牙医院ICU的休克患者,发现队列109例、验证队列52例,于休克诊断后24小时内采集血浆行miRNA测序。发现队列中鉴定出30个在脓毒性与非脓毒性休克间显著差异表达的miRNA,其中6个(miR-100-5p、miR-484、miR-10a-5p、miR-148a-3p、miR-342-3p、miR-451a)诊断能力较强。miR-100-5p、miR-148a-3p、miR-451a三联组合AUC为0.894,验证队列qPCR验证AUC为0.960。作者认为该三联标志物有潜力提升术后患者脓毒性休克的诊断,从而协助及时恰当的治疗。
要点
- 术后休克患者中,miR-100-5p、miR-148a-3p、miR-451a三联组合鉴别脓毒性休克与非脓毒性休克的AUC为0.894。
- 验证队列qPCR验证该三联标志物的AUC为0.960。
- 发现队列与验证队列分别于休克诊断后24小时内采集血浆行miRNA测序。
- 共鉴定出30个在脓毒性与非脓毒性休克间显著差异表达的miRNA,其中6个诊断能力较强。
- 作者认为该三联标志物有潜力提升术后患者脓毒性休克的诊断,协助及时恰当的治疗。
适用人群与场景
- 两所西班牙医院ICU的休克患者,分为发现队列109例与验证队列52例。
- 血浆样本于休克诊断后24小时内采集。
研究设计与关键结果
- 多中心前瞻性研究,发现队列109例、验证队列52例,均来自两所西班牙医院ICU。
- 发现队列通过高通量测序鉴定出30个在脓毒性与非脓毒性休克间显著差异表达的miRNA。
- 其中6个miRNA(miR-100-5p、miR-484、miR-10a-5p、miR-148a-3p、miR-342-3p、miR-451a)显示出较强的脓毒性休克诊断能力。
- miR-100-5p、miR-148a-3p、miR-451a三联组合的AUC为0.894。
- 验证队列qPCR验证该三联标志物的AUC为0.960。
证据类型、等级与局限
- 证据类型:多中心前瞻性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,外泌体来源miRNA是有前景的鉴别脓毒性与非脓毒性休克的生物标志物。
- 作者认为,所鉴定的三联miRNA标志物有显著潜力提升脓毒性休克诊断,从而协助术后患者及时和恰当的治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Diagnosing septic shock promptly is essential but challenging, especially due to its clinical similarity to non-septic shock. Extracellular vesicle-derived miRNAs may serve as biomarkers to distinguish septic shock from non-septic shock, providing a more accurate diagnostic tool for postsurgical patients. This study aims to identify extracellular vesicle-derived miRNA signatures that differentiate septic shock from non-septic shock in postsurgical patients, potentially improving diagnostic accuracy and clinical decision-making.
METHODS: A multicentre, prospective study was conducted on miRNA profiles in shock patients. Two cohorts were recruited from the Intensive Care Units of two Spanish hospitals: a discovery cohort with 109 patients and a validation cohort with 52 patients. Plasma samples were collected within 24 h of shock diagnosis and subjected to miRNA sequencing. High-throughput sequencing data from the discovery cohort were analysed to identify differentially expressed miRNAs. These findings were validated via qPCR in the validation cohort.
RESULTS: Thirty miRNAs were identified as significantly differentially expressed between septic and non-septic shock patients. Among these, six miRNAs-miR-100-5p, miR-484, miR-10a-5p, miR-148a-3p, miR-342-3p, and miR-451a-demonstrated strong diagnostic capabilities for septic shock. A combination of miR-100-5p, miR-148a-3p, and miR-451a achieved an area under the curve of 0.894, with qPCR validation in the validation cohort yielding an area under the curve of 0.960.
CONCLUSIONS: This study highlights extracellular vesicle-derived miRNAs as promising biomarkers for differentiating septic from non-septic shock. The identified three-miRNA signature has significant potential to enhance septic shock diagnosis, thereby aiding in timely and appropriate treatment for postsurgical patients.
参考来源
- García-Concejo A, Sánchez-Quirós B, Gómez-Sánchez E, et al. Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients. Crit Care. 2025. PMID: 40033446. doi:10.1186/s13054-025-05320-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。